De Montigny C[au] - Search Results

Year	Number of Results
1970	1
1971	1
1973	1
1974	1
1975	2
1977	2
1978	1
1979	4
1980	3
1981	4
1982	3
1983	5
1984	6
1985	7
1986	4
1987	10
1988	9
1989	9
1990	14
1991	7
1992	10
1993	7
1994	9
1995	9
1996	12
1997	7
1998	14
1999	9
2000	6
2001	1
2004	3
2006	2
2007	3
2009	1
2011	1
2018	1
2021	0

1

Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.

Piguet F, de Montigny C, Vaucamps N, Reutenauer L, Eisenmann A, Puccio H. Piguet F, et al. Among authors: de montigny c. Mol Ther. 2018 Aug 1;26(8):1940-1952. doi: 10.1016/j.ymthe.2018.05.006. Epub 2018 May 28. Mol Ther. 2018. PMID: 29853274 Free PMC article.

2

Current advances and trends in the treatment of depression.

Blier P, de Montigny C. Blier P, et al. Among authors: de montigny c. Trends Pharmacol Sci. 1994 Jul;15(7):220-6. doi: 10.1016/0165-6147(94)90315-8. Trends Pharmacol Sci. 1994. PMID: 7940983 Review.

3

Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.

Blier P, Piñeyro G, el Mansari M, Bergeron R, de Montigny C. Blier P, et al. Among authors: de montigny c. Ann N Y Acad Sci. 1998 Dec 15;861:204-16. doi: 10.1111/j.1749-6632.1998.tb10192.x. Ann N Y Acad Sci. 1998. PMID: 9928258 Review.

4

Treatment resistant depression: methodological overview and operational criteria.

Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J. Souery D, et al. Among authors: de montigny c. Eur Neuropsychopharmacol. 1999 Jan;9(1-2):83-91. doi: 10.1016/s0924-977x(98)00004-2. Eur Neuropsychopharmacol. 1999. PMID: 10082232 Review.

5

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

Blier P, de Montigny C. Blier P, et al. Among authors: de montigny c. Biol Psychiatry. 1998 Sep 1;44(5):313-23. doi: 10.1016/s0006-3223(98)00114-0. Biol Psychiatry. 1998. PMID: 9755353 Review.

6

Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission.

Blier P, de Montigny C. Blier P, et al. Among authors: de montigny c. Psychopharmacol Ser. 1987;3:127-34. doi: 10.1007/978-3-642-71288-3_15. Psychopharmacol Ser. 1987. PMID: 3029752 Review. No abstract available.

7

The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments.

Mongeau R, Blier P, de Montigny C. Mongeau R, et al. Among authors: de montigny c. Brain Res Brain Res Rev. 1997 Apr;23(3):145-95. doi: 10.1016/s0165-0173(96)00017-3. Brain Res Brain Res Rev. 1997. PMID: 9164669 Review.

8

Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.

Haddjeri N, Blier P, de Montigny C. Haddjeri N, et al. Among authors: de montigny c. Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:11-7. doi: 10.1097/00004850-199512004-00003. Int Clin Psychopharmacol. 1995. PMID: 8930005 Review.

9

A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.

Blier P, de Montigny C, Chaput Y. Blier P, et al. Among authors: de montigny c. J Clin Psychiatry. 1990 Apr;51 Suppl:14-20; discussion 21. J Clin Psychiatry. 1990. PMID: 2157700 Review.

10

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.

Blier P, de Montigny C. Blier P, et al. Among authors: de montigny c. Neuropsychopharmacology. 1999 Aug;21(2 Suppl):91S-98S. doi: 10.1016/S0893-133X(99)00036-6. Neuropsychopharmacology. 1999. PMID: 10432494 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results